INS and diabetes mellitus: On receiving the first dose of vaccination for SARS-CoV-2, the patient developed localized symptoms, but two days after receiving the second dose, the patient developed typical symptoms of diabetes mellitus with weight loss, investigations showing low C peptide levels, high blood glucose levels, and insulin resistance that were treated first with intravenous insulin and later with intracutaneous insulin after two days.